Posted on May 24, 2004, 5 a.m.
By Bill Freeman
BusinessWeek takes a tour of the mainstream medical research business - big pharma and the new biotech giants - to see how they are starting to pour money into regenerative medicine. Much of the focus today is on repairing damage to the "engines of life," the heart and brain, but an amazing variety of privately funded work is taking place.
View the Article Under Discussion: http://www.businessweek.com/magazine/content/04_21/b3884001_mz001.htm
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/